Trial Profile
Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2016 New trial record